Cargando…

Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis

Detalles Bibliográficos
Autores principales:	Majerníková, Nad'a, den Dunnen, Wilfred F. A., Dolga, Amalia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959210/ https://www.ncbi.nlm.nih.gov/pubmed/35356295 http://dx.doi.org/10.3389/fnagi.2022.863205

Ejemplares similares

The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad’a, et al.
Publicado: (2021)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Constructing a prognostic risk model for Alzheimer’s disease based on ferroptosis
por: Wang, Xiao-Li, et al.
Publicado: (2023)

lncRNA-associated ceRNA network revealing the potential regulatory roles of ferroptosis and immune infiltration in Alzheimer’s disease
por: Tan, Yejun, et al.
Publicado: (2023)

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
por: Sun, Yiyan, et al.
Publicado: (2022)

Ferroptosis: a new regulatory mechanism in neuropathic pain
por: Li, Lu, et al.
Publicado: (2023)

Identification of Potential Driver Genes and Pathways Based on Transcriptomics Data in Alzheimer's Disease
por: Xia, Liang-Yong, et al.
Publicado: (2022)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Corrigendum: Alzheimer-compound identification based on data fusion and forgeNet_SVM
por: Yang, Bin, et al.
Publicado: (2023)

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
por: Chen, Yanting, et al.
Publicado: (2023)

Corrigendum: Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease
por: Chen, Chen, et al.
Publicado: (2021)

Corrigendum: A 5-min Cognitive Task With Deep Learning Accurately Detects Early Alzheimer's Disease
por: Almubark, Ibrahim, et al.
Publicado: (2022)

Sensogenomics of music and Alzheimer’s disease: An interdisciplinary view from neuroscience, transcriptomics, and epigenomics
por: Navarro, Laura, et al.
Publicado: (2023)

Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models
por: Wang, Yi-Wei, et al.
Publicado: (2022)

Corrigendum: Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer's disease: a bibliometric analysis
por: Zou, Yutong, et al.
Publicado: (2023)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Research progress of ferroptosis in Parkinson’s disease: a bibliometric and visual analysis
por: Lu, Yangguang, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

Corrigendum: Hippocampus of the APP(NL−G−F) mouse model of Alzheimer's disease exhibits region-specific tissue softening concomitant with elevated astrogliosis
por: Hall, Chloe M., et al.
Publicado: (2023)

Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging
por: Peng, Shouneng, et al.
Publicado: (2021)

Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain
por: Mei, Taoyu, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Editorial: Novel mechanisms involved in aging and neurodegeneration: Seeking potential therapeutic targets for neurodegenerative diseases
por: Sanhueza, Mario, et al.
Publicado: (2022)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
por: Liu, Lihua, et al.
Publicado: (2022)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
por: Hershkovits, Ayelet Sarah, et al.
Publicado: (2023)

Corrigendum: Reduced insulin signaling targeted to serotonergic neurons but not other neuronal subtypes extends lifespan in Drosophila melanogaster
por: Dravecz, Nikolett, et al.
Publicado: (2023)

Development of a diagnostic and risk prediction model for Alzheimer’s disease through integration of single-cell and bulk transcriptomic analysis of glutamine metabolism
por: Guo, Yan, et al.
Publicado: (2023)

Platelet Activating Factor Receptor Exaggerates Microglia-Mediated Microenvironment by IL10-STAT3 Signaling: A Novel Potential Biomarker and Target for Diagnosis and Treatment of Alzheimer’s Disease
por: Liu, Junxiu, et al.
Publicado: (2022)

Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias
por: Giménez-Llort, Lydia
Publicado: (2023)

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
por: Chen, Huiyi, et al.
Publicado: (2022)

Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2023)

Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2(*)R47H
por: Kotredes, Kevin P., et al.
Publicado: (2022)

Application of weighted co-expression network analysis and machine learning to identify the pathological mechanism of Alzheimer's disease
por: Chai, Keping, et al.
Publicado: (2022)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9ttas0k4j66n50qt7peol9mti